Corvus Pharmaceuticals (CRVS) Change in Accured Expenses (2015 - 2026)
Corvus Pharmaceuticals' Change in Accured Expenses was $2.19 million in Q2 2026, up 91.4% from $1.14 million a year earlier and up 338.1% from the prior quarter.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Change in Accured Expenses (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Corvus Pharmaceuticals' Change in Accured Expenses was $4.16 million through Jun 30, 2026, up 486.5% year-over-year; for FY2025, it came in at $2.76 million.
- Change in Accured Expenses shows a five-year compound annual growth rate of 31.4% (FY2020 to FY2025).
- In earlier years, Change in Accured Expenses was -$245,000 in FY2024, -$3.58 million in FY2023, $467,000 in FY2022 and -$523,000 in FY2021.
- The Q2 2026 figure marks the highest quarterly Change in Accured Expenses since Q3 2022.
- Per Business Quant data, CRVS's Change in Accured Expenses in the three quarters before Q2 2026 was $499,000 (Q1 2026), $765,000 (Q4 2025) and $708,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Corvus Pharmaceuticals | 916.92 Mn | 405.36 Mn | - | 2.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.19 Mn |
| Mar 31, 2026 | 499,000.00 |
| Dec 31, 2025 | 765,000.00 |
| Sep 30, 2025 | 708,000.00 |
| Jun 30, 2025 | 1.14 Mn |
| Mar 31, 2025 | 146,000.00 |
| Dec 31, 2024 | -490,000.00 |
| Sep 30, 2024 | -89,000.00 |
| Jun 30, 2024 | 233,000.00 |
| Mar 31, 2024 | 101,000.00 |
| Dec 31, 2023 | -589,000.00 |
| Sep 30, 2023 | 98,000.00 |
| Jun 30, 2023 | -1.16 Mn |
| Mar 31, 2023 | -1.93 Mn |
| Dec 31, 2022 | -1.02 Mn |
| Sep 30, 2022 | 2.20 Mn |
| Jun 30, 2022 | 385,000.00 |
| Mar 31, 2022 | -1.10 Mn |
| Dec 31, 2021 | -875,000.00 |
| Sep 30, 2021 | -386,000.00 |
API Access
Corvus Pharmaceuticals Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();